ProShare Advisors LLC Reduces Position in Danaher Corporation $DHR

ProShare Advisors LLC lessened its position in Danaher Corporation (NYSE:DHR) by 2.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 114,358 shares of the conglomerate’s stock after selling 2,551 shares during the period. ProShare Advisors LLC’s holdings in Danaher were worth $22,673,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Sivia Capital Partners LLC lifted its position in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after purchasing an additional 119 shares during the period. Concurrent Investment Advisors LLC increased its position in shares of Danaher by 14.0% during the second quarter. Concurrent Investment Advisors LLC now owns 11,459 shares of the conglomerate’s stock valued at $2,264,000 after buying an additional 1,411 shares during the period. CWM LLC raised its stake in Danaher by 19.9% in the second quarter. CWM LLC now owns 36,941 shares of the conglomerate’s stock worth $7,297,000 after buying an additional 6,130 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Danaher by 579.2% in the second quarter. Allspring Global Investments Holdings LLC now owns 375,863 shares of the conglomerate’s stock worth $75,586,000 after buying an additional 320,521 shares during the period. Finally, Vest Financial LLC boosted its position in Danaher by 39.2% during the 2nd quarter. Vest Financial LLC now owns 7,465 shares of the conglomerate’s stock valued at $1,475,000 after acquiring an additional 2,104 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.4%

Danaher stock opened at $219.66 on Wednesday. Danaher Corporation has a one year low of $171.00 and a one year high of $242.80. The business’s fifty day moving average is $229.33 and its 200 day moving average is $215.37. The stock has a market capitalization of $155.16 billion, a PE ratio of 43.58, a price-to-earnings-growth ratio of 2.93 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter last year, the company posted $2.14 earnings per share. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. On average, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were given a $0.32 dividend. The ex-dividend date was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is presently 25.40%.

Insider Activity at Danaher

In related news, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Wells Fargo & Company increased their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Leerink Partners boosted their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. The Goldman Sachs Group reduced their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Finally, TD Cowen reissued a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Twenty investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.